Home

Scott N. Boyle, Chief Business Officer: C4 Therapeutics CCCC Sell · Filed 25/02/18

Trade details

Type
Insider sale
Amount
$1,543.5
Shares · price
490 sh · $3.15 a share
Held after
110,842 sh
Trade date
25/02/14
Filed
25/02/18
Days to filing
4 days

Sold 0.4% of holdings

Share of holding sold
0.4%

C4 Therapeutics trades, last 26 weeks

What else happened in C4 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/15~25/03/16

Scott N. Boyle's recent trades

  • Scott N. Boyle

    Sell10b5-1 planC4 Therapeutics

    $2,107

    Filed 25/02/18

Scott N. Boyle, Chief Officer — sold $1,544 of C4 Therapeutics CCCC · 0.4% of holdings · 10b5-1 plan | Whalegun